After three kinds of GIST cells were treated with imatinib, the following figure showed that the expression of FABP4, COL4A1, and RGS4 in imatinib-sensitive lines GIST882 and GIST-T1 decreased significantly compared with GIST430 cell lines. This evidence concerns the gene COL4A1 and gastrointestinal stromal tumor.